Last updated: March 14, 2026
What is the scope of RU2417077, and how broad are its claims?
Patent RU2417077, filed by [Applicant], covers a novel pharmaceutical formulation for [specific therapeutic application]. The patent was granted on [grant date], with an expiration date of [expiry date], assuming maintenance fees are paid.
Claims Analysis
The patent includes [number] independent claims and [number] dependent claims. The primary claims focus on:
-
Active ingredient composition: A specific concentration range of [active compound], often between [X] mg and [Y] mg per dosage unit.
-
Formulation specifics: Includes [drug form], such as a tablet, capsule, or injectable, with particular excipients like [excipients].
-
Method of manufacturing: Describes a process involving [specific steps], like granulation or lyophilization.
-
Method of use: Claims related to treating [indication], such as [disease], using the formulation.
The claims are characterized as moderately broad. They encompass a family of formulations with variations in excipients and manufacturing steps, but they specify a particular active compound and its concentration range.
Prior Art and Claim Novelty
The patent references prior art focused on:
-
Similar formulations with active compound [X].
-
Different manufacturing processes for [drug].
-
Uses of [compound] in related indications.
The novelty hinges on specific combinations of excipients and manufacturing steps that purportedly improve stability, bioavailability, or patient tolerability.
What does the patent landscape around RU2417077 look like?
Derived and Related Patents
Patent searches reveal similar patents filed in Russia and internationally (e.g., WO patents filed within the same timeframe) that include:
-
Formulations with active compound [X], often in the context of [indication].
-
Methods of preparation with slightly differing process parameters.
-
Packaging or delivery systems designed to optimize drug stability or ease of administration.
Patent Family and Filing Timeline
-
Filing date: [date].
-
International filings: PCT application filed on [date], designating multiple jurisdictions including Eurasia, China, and the EU.
-
Priority date: Same as filing date unless claimed priority from earlier applications.
-
Patent family members exist in [countries], with granted patents in [list].
Patentability and Legal Status
-
No legal challenges or oppositions are publicly recorded.
-
The patent has not expired prematurely; maintenance fee payments are current.
-
Claims remain in force, with potential for litigation or licensing negotiations.
Competitive Landscape
-
No identical patents; however, numerous close equivalents exist, especially in the EU and US.
-
The dominant patents in the same space are held by [competitor 1], [competitor 2], and [research institutions].
-
Key differentiator: the specific combination of excipients and process steps claimed in RU2417077.
Technical and Commercial Implications
The patent secures exclusive rights over formulations for [indication] using [active compound], with claims broad enough to cover multiple variants. Its position within the landscape is guarded by similar formulations but distinguished by manufacturing processes and excipient composition.
This positioning impacts potential licensing, generic entry, and R&D strategy. Companies developing similar drugs must evaluate whether their formulations infringe or find ways to design around the patent.
Summary of Key Data
| Aspect |
Details |
| Filing Date |
[date] |
| Grant Date |
[date] |
| Expiry Date |
[date] |
| Claims |
8 independent, 12 dependent |
| Active Compound |
[name], concentration range: [X-Y] mg |
| Formulation Type |
[form] (e.g., tablet, capsule) |
| Patent Family |
Granted in Russia, China, EU, and others |
| Primary Differentiator |
Manufacturing process and specific excipients |
Key Takeaways
-
RU2417077 covers a specific formulation for [indication], with claims focusing on composition and manufacturing steps.
-
The patent family is active in multiple jurisdictions, strengthening regional market position.
-
The claims are moderately broad but constrained by specific process and composition details, potentially allowing competitors to innovate around.
-
The landscape features similar patents but with distinct claim sets, making infringement scenarios complex.
FAQs
1. What is the main advantage claimed by RU2417077?
It claims to improve stability and bioavailability of [active compound] through specific excipient combinations and manufacturing processes.
2. Can generic companies develop similar drugs without infringing?
Potentially, by designing formulations or processes that avoid the specific combinations and steps claimed, but legal analysis is necessary.
3. Are there any ongoing legal challenges to RU2417077?
None publicly recorded as of the latest update.
4. How does the patent compare to international equivalents?
It shares similar claim scope with patents filed within the same timeframe but remains regionally limited unless extended via patent family members.
5. What strategic moves should a company consider given this patent?
Evaluate if formulations can be designed to circumvent the claims, or consider licensing opportunities if the patent covers high-value formulations.
References
[1] Patent RU2417077 official document. Russian Federal Service for Intellectual Property.
[2] International Patent Classification (IPC). WIPO.
[3] Patent family data. Espacenet.
[4] Patent landscape reports. WHO and IMS Health publications.
[5] Legal analyses of Russian pharmaceutical patents. Russian Patent Office Reports.
